Advanced search
Publication Cover
Research Reports in Clinical Cardiology Volume 12, 2021 - Issue
Submit an article Journal homepage
126
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Dasatinib-Induced Pulmonary Arterial Hypertension: A Case Report

Ru Liu1 Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China;2 Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Kunming, Yunnan Province, People’s Republic of China
,
Yinjiang Tang2 Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Kunming, Yunnan Province, People’s Republic of China
,
Ting Fu2 Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Kunming, Yunnan Province, People’s Republic of China
,
Jianli Zhou2 Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Kunming, Yunnan Province, People’s Republic of China
,
Lijiao Ma2 Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Kunming, Yunnan Province, People’s Republic of China
,
Jinqing Yuan1 Department of Cardiology, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of ChinaCorrespondence[email protected]
&
Ou Xu2 Department of Pulmonary Vascular and General Medicine, Fuwai Yunnan Cardiovascular Hospital, Yunnan Provincial Cardiovascular Disease Clinical Medical Center, Kunming, Yunnan Province, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 33-39 | Published online: 10 Aug 2021

References

  • Ryan JJ. Tyrosine kinase inhibitors in pulmonary vascular disease. JACC: Basic Transl Sci. 2016;1(7):684–686.
  • Yurttaş NÖ, Eşkazan AE. Dasatinib‐induced pulmonary arterial hypertension. Br J Clin Pharmacol. 2018;84(5):835–845. doi:10.1111/bcp.13508
  • Weatherald J, Chaumais MC, Savale L, et al. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. Eur Respir J. 2017;50(1):1700217. doi:10.1183/13993003.00217-2017
  • Mattei D, Feola M, Orzan F, Mordini N, Rapezzi D, Gallamini A. Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient. Bone Marrow Transplant. 2009;43(12):967–968. doi:10.1038/bmt.2008.415
  • Toya T, Nagatomo Y, Kagami K, Adachi T. Dasatinib-induced pulmonary arterial hypertension complicated with scleroderma: a case report. Eur Heart J Case Rep. 2019;3(1):ytz025. doi:10.1093/ehjcr/ytz025
  • Guignabert C, Phan C, Seferian A, et al. Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. J Clin Invest. 2016;126(9):3207–3218. doi:10.1172/JCI86249
  • Shah NP, Wallis N, Farber HW, et al. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib. Am J Hematol. 2015;90(11):1060–1064. doi:10.1002/ajh.24174
  • Xu XQ, Jing ZC. The 6th world symposium on pulmonary hypertension: focus on updates on definition and clinical classification of pulmonary hypertension. Med J PUMCH. 2018;9(3):197–201.
  • Hong JH, Lee SE, Choi SY, et al. Reversible pulmonary arterial hypertension associated with dasatinib for chronic myeloid leukemia. Cancer Res Treat. 2015;47(4):937–942. doi:10.4143/crt.2013.155
  • Paydas S. Dasatinib, large granular lymphocytosis, and pleural effusion: useful or adverse effect? Crit Rev Oncol Hematol. 2014;89(2):242–247. doi:10.1016/j.critrevonc.2013.10.005
  • Ouintas-Cardama A, Kantarjian H, O’Brien S, et al. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure. J Clin Oncol. 2007;25(25):3908–3914. doi:10.1200/JCO.2007.12.0329
  • Liu BC, Wang Y, Mi YC, Wang JX.. Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review. Chin J Hematol. 2014;35(7):581–586. doi:10.3760/cma.j.issn.0253-2727.2014.07.002

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.